Skip to main content

Advertisement

Log in

Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double-blinded randomized controlled trial

  • Original Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Background

Awake fiberoptic nasotracheal intubation is usually performed in patients with an anticipated difficult airway. This study compares dexmedetomidine and remifentanil for conscious sedation during fiberoptic intubation.

Methods

Forty patients undergoing elective awake fiberoptic nasotracheal intubation were allocated randomly to receive either dexmedetomidine (n = 20) or remifentanil (n = 20). Primary outcome measures were endoscopy, intubation, and post-intubation conditions as scored by the attending anesthesiologist. Other parameters included the time taken to achieve the desired level of sedation, endoscopy time, intubation time, and hemodynamic changes during the procedure. An interview was conducted 24 h after surgery to evaluate patients’ recall of and satisfaction with the procedure.

Results

The median [interquartile range] endoscopy score (graded 0–5) in the dexmedetomidine group (2 [1–2]) was significantly better than in patients who received remifentanil (3 [2–3]; p < 0.01). Recall of intubation was significantly lower in the dexmedetomidine group (p = 0.027). Dexmedetomidine provided better patient satisfaction than remifentanil (2 [1–2] and 2 [2–3], respectively; p = 0.022). Patients in the dexmedetomidine group had fewer heart rate responses during endoscopy and intubation as compared to the remifentanil group (p < 0.001 and p = 0.004, respectively). Peripheral oxygen saturation was less in the remifentanil group during endoscopy (p = 0.003). There were no significant differences in intubation and post-intubation conditions.

Conclusions

Both dexmedetomidine and remifentanil were effective as sedatives in patients undergoing awake fiberoptic nasotracheal intubation. Compared with remifentanil, dexmedetomidine offered better endoscopy scores, lower recall of intubation, and greater patient satisfaction, with minor hemodynamic side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Grant S, Noble S, Woods A, Murdoch J, Davidson A. Assessment of intubating conditions in adults after induction with propofol and varying doses of remifentanil. Br J Anaesth. 1998;81:540–3.

    Article  PubMed  CAS  Google Scholar 

  2. Cafiero T, Esposito F, Fraioli G, Gargiulo G, Frangiosa A, Cavallo LM, Mennella N, Cappabianca P. Remifentanil-TCI and propofol-TCI for conscious sedation during fibreoptic intubation in the acromegalic patient. Eur J Anaesthesiol. 2008;25(8):670–4.

    Article  PubMed  CAS  Google Scholar 

  3. Neidhart G, Bremerich DH, Kessler P. Fibreoptic intubation during remifentanil/propofol sedation. Anaesthetist. 2001;50:242–7.

    Article  CAS  Google Scholar 

  4. Scher C, Gitlin M. Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation. Can J Anesth. 2003;50:607–10.

    Article  PubMed  Google Scholar 

  5. Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short acting, mu-opoid. Anesth Analg. 1996;83:646–51.

    PubMed  CAS  Google Scholar 

  6. Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth. 2007;19:370–3.

    Article  Google Scholar 

  7. Avitsian R, Lin J, Lotto M, Ebrahim Z. Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series. J Neurosurg Anesth. 2005;17:97–9.

    Article  Google Scholar 

  8. Grant SA, Breslin DS, MacLeod DB, Gleason D, Martin G. Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases. J Clin Anesth. 2004;16:124–6.

    Article  PubMed  CAS  Google Scholar 

  9. Stamenkovic DM, Hassid M. Dexmedetomidine for fiberoptic intubation of a patient with severe mental retardation and atlantoaxial instability. Acta Anaesthesiol Scand. 2006;50:1314–5.

    Article  PubMed  CAS  Google Scholar 

  10. Bergese SD, Candiotti KA, Bokesch PM, Zura A, Wisemandle W, Bekker AY; AWAKE Study Group. A phase IIIb, randomized double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. Am J Ther. 2010;17:586–95.

    Google Scholar 

  11. Chu KS, Wang FY, Hsu HT, Lu IC, Wang HM, Tsai CJ. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. Eur J Anaesthesiol. 2010;27:36–40.

    Article  PubMed  CAS  Google Scholar 

  12. Abdelmalak B, Makary L, Hoban J, Doyle DJ. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth. 2007;19:370–3.

    Article  PubMed  CAS  Google Scholar 

  13. Madhere M, Vangura D, Saidov A. Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy. J Anesth. 2011;25(4):592–4.

    Article  PubMed  Google Scholar 

  14. Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double blinded randomized controlled trial. Br J Anaesth. 2008;100:125–30.

    Article  PubMed  CAS  Google Scholar 

  15. Lallo A, Billard FV, Bourgain JL. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg. 2009;108:852–7.

    Article  PubMed  CAS  Google Scholar 

  16. Tsai CJ, Chu KS, Chen TI, Lu DV, Wang HM, Lu IC. A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia. 2010;65:254–9.

    Article  PubMed  CAS  Google Scholar 

  17. Asai T, Shingu K. Difficulty in advancing a tracheal tube over a fibreoptic bronchoscope: incidence, causes and solutions. Br J Anaesth. 2004;92:870–81.

    Article  PubMed  CAS  Google Scholar 

  18. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–94.

    Article  PubMed  CAS  Google Scholar 

  19. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302–8.

    Article  PubMed  CAS  Google Scholar 

  20. Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H. Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology. 1990;73:230–5.

    Article  PubMed  CAS  Google Scholar 

  21. Scher CS, Gitlin MC. Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation. Can J Anaesth. 2003;50:607–10.

    Article  PubMed  Google Scholar 

  22. Puchner W, Egger P, Pühringer F, Löckinger A, Obwegeser J, Gombotz H. Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand. 2002;46:350–4.

    Article  PubMed  CAS  Google Scholar 

  23. Machata AM, Gonano C, Holzer A, Andel D, Spiss CK, Zimpfer M, Illievich UM. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg. 2003;97:904–8.

    Article  PubMed  CAS  Google Scholar 

  24. Puchner W, Obwegeser J, Puhringer FK. Use of remifentanil for awake fiberoptic intubation in a morbidly obese patient with severe inflammation of the neck. Acta Anaesthesiol Scand. 2002;46:473–6.

    Article  PubMed  CAS  Google Scholar 

  25. Mingo OH, Ashpole KJ, Irving CJ, Rucklidge MWM. Remifentanil sedation for awake fibreoptic intubation with limited application of local anaesthetic in patients for elective head and neck surgery. Anaesthesia. 2008;63:1065–9.

    Article  PubMed  CAS  Google Scholar 

  26. Vennila R, Hall A, Ali M, Bhuiyan N, Pirotta D, Raw DA. Remifentanil as single agent to facilitate awake fibreoptic intubation in the absence of premedication. Anaesthesia. 2011;66:368–72.

    Article  PubMed  CAS  Google Scholar 

  27. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in human. II. Hemodynamic changes. Anesthesiology. 1992;77:1134–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hong Jiang.

Appendix 1

Appendix 1

Endoscopy score 0, 1, 2, 3, 4, 5

Grimacing

Localizing

Coughing on lidocaine via scope

Coughing on entering infraglottic space

Prolonged coughing

Intubation score 0, 1, 2, 3, 4, 5

Grimacing when tube in nares

Localizing with one limb at any stage

Localizing with two limbs at any stage

Coughing on entering trachea

Prolonged coughing

Post-intubation score 1, 2, 3

1 Cooperative, obeying commands

2 Uncomfortable, GA imminent

3 Other (specify)

Postoperative interview

Amnesia

Recall of endoscopy: Yes, No

Recall of intubation: Yes, No

Adverse events

Sore throat: Yes, No

Hoarseness: Yes, No

Satisfaction score: 1, 2, 3, 4

Excellent

Good

Acceptable

Poor

About this article

Cite this article

Hu, R., Liu, J.X. & Jiang, H. Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double-blinded randomized controlled trial. J Anesth 27, 211–217 (2013). https://doi.org/10.1007/s00540-012-1499-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-012-1499-y

Keywords

Navigation